Quay Pharmaceuticals Sets Up Headquarters in Wales
North Wales - November 10, 2009
Quay Pharmaceuticals is investing £2.7million in a new headquarters and manufacturing facility in North Wales where, with support from the Welsh Assembly Government, it will create 54 new high quality jobs. Operations at the new site will include early stage research & development and clinical trials manufacturing for the global pharmaceutical and biotechnology industries.
Quay Pharma is a welcome addition to the healthcare and bioscience sector in Wales which employs some 15,000 people and is worth around £1.3billion annually to the Welsh economy. Support was provided through the Single Investment Fund to facilitate the company’s expansion programme, said Ieuan Wyn Jones, Minister for the Economy and Transport.
“Quay Pharma will be creating a range of high quality jobs over the next few years providing excellent employment opportunities for Welsh graduates,” said Wyn Jones.
The range of support offered by the Assembly Government to small and medium sized businesses had made Wales an attractive proposition for Quay Pharma’s expansion, Chief Executive Officer Mike Rubinstein said.
“The support from the Assembly Government is great for a small company and of particular help in the current economic climate. Not only does it provide advice and access to knowledge but also provides businesses with a high level of promotional and marketing support at overseas events," Rubenstein said.
The company is currently fitting out laboratories and offices with the aim of opening in January. The manufacturing operation is due to relocate during the first quarter of next year.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
